Combined kinase inhibitors of MEK1/2 and either PI3K or...

  • Main
  • 2017 / 05
  • Combined kinase inhibitors of MEK1/2 and either PI3K or...
Neuro-Oncology 2017 / 05

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer

Van Swearingen, Amanda E. D., Sambade, Maria J., Siegel, Marni B., Sud, Shivani, McNeill, Robert S., Bevill, Samantha M., Chen, Xin, Bash, Ryan E., Mounsey, Louisa, Golitz, Brian T., Santos, Charlene,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nox052
Date:
May, 2017
File:
PDF, 3.26 MB
english, 2017
Conversion to is in progress
Conversion to is failed